ST. PAUL, Minn. (AP) — The federal government now says 111 Minnesota clinics received drugs from a Massachusetts pharmacy at the center of a fungal meningitis outbreak. That’s 18 fewer clinics than state officials reported last week after receiving a different provider list, and they don’t know why the number changed.

Only one steroid made by New England Compounding Center has been linked to the fungal meningitis outbreak. But the Food and Drug Administration warns it can’t verify the safety of other drugs made at the facility.

READ MORE: Looking To Trade In Your Old Vehicle? Now May Be The Best Time Ever To Do So

Assistant State Epidemiologist Richard Danila tells Minnesota Public Radio the lower number of clinics is confusing, and that the FDA hasn’t been helpful.

READ MORE: Minnesotan Reyel Simmons Charged With Impersonating Homeland Security Agent On TikTok

An FDA spokeswoman did not immediately return a call from The Associated Press seeking comment.

MORE NEWS: Tornado Sirens Didn't Sound Off Friday In At Least 3 Twin Cities Suburbs

Minnesota has nine confirmed cases of fungal meningitis so far.